(Q80521843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrew M Evens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Trifilio S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Singhal S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Williams S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Frankfurt O

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Winter J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tallman M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pi J

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Mehta J

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

25 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

451-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589527%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705754

1 January 2020

exact match

0 references

cites work

Emerging fungal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Aspergillus infections in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Voriconazole therapeutic drug monitoring.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Development and validation of a high-performance liquid chromatography assay for voriconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705754

7 January 2021